What is Acino Holding AG Cash-to-Debt?
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Acino Holding AG's cash to debt ratio for the quarter that ended in Dec. 2013 was 0.09.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Acino Holding AG couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2013.
The historical rank and industry rank for Acino Holding AG's Cash-to-Debt or its related term are showing as below:
XSWX:ACIN'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09 Med: No Debt Max: No Debt
Current: 0.09
During the past 11 years, Acino Holding AG's highest Cash to Debt Ratio was No Debt. The lowest was 0.09. And the median was No Debt.
Acino Holding AG Cash-to-Debt Historical Data
The historical data trend for Acino Holding AG's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Acino Holding AG Cash-to-Debt Chart
|
Acino Holding AG Annual Data
|
|
Trend |
Dec04 |
Dec05 |
Dec06 |
Dec07 |
Dec08 |
Dec09 |
Dec10 |
Dec11 |
Dec12 |
Dec13 |
| Cash-to-Debt |
|
Get a 7-Day Free Trial
|
|
|
No Debt |
No Debt |
No Debt |
0.15 |
0.09 |
|
Acino Holding AG Semi-Annual Data
|
|
Dec03 |
Dec04 |
Dec05 |
Dec06 |
Dec07 |
Dec08 |
Dec09 |
Dec10 |
Dec11 |
Dec12 |
Dec13 |
| Cash-to-Debt |
Get a 7-Day Free Trial
|
|
|
|
No Debt |
No Debt |
No Debt |
0.15 |
0.09 |
Competitive Comparison of Acino Holding AG's Cash-to-Debt
For the Drug Manufacturers - General subindustry, Acino Holding AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acino Holding AG's Cash-to-Debt Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Acino Holding AG's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Acino Holding AG's Cash-to-Debt falls into.
Acino Holding AG Cash-to-Debt Calculation
This is the ratio of a company's
Cash, Cash Equivalents, Marketable Securities
to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Acino Holding AG's Cash to Debt Ratio for the fiscal year that ended in Dec. 2013 is calculated as:
Acino Holding AG's Cash to Debt Ratio for the quarter that ended in Dec. 2013 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acino Holding AG (XSWX:ACIN) Business Description
Traded in Other Exchanges
N/A
Address
Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.
Acino Holding AG (XSWX:ACIN) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:ACIN has been successfully added to your